effectiveness of sensor-augmented insulin-pump by changing MiniMed 770G in type 1 diabetes patients

effectiveness of sensor-augmented insulin-pump by changing MiniMed 770G in type 1 diabetes patients - effectiveness of sensor-augmented insulin-pump by changing MiniMed 770G in type 1 diabetes patients

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000048859

Enrollment

Registered

2022-09-12

Start date

2022-03-11

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

type 1 diabetes mellitus

Interventions

Change from 640 to 770.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: The patients with type 1 diabetes using minimed 770

Exclusion criteria

Exclusion criteria: The patients with type 2 diabetes and gestational diabetes

Design outcomes

Primary

Measure	Time frame
The primary endpoint was the change from baseline body weight, glucose variability and insulin units.	—

Countries

Japan

Contacts

Public ContactFuchigami Ayako

Toho University Graduate School of Medicine Division of Diabetes, Metabolism, and Endocrinology, Departmet of Medicine

ayako.fuchigami@med.toho-u.ac.jp03-3762-4151

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026